“Relapse”的搜索结果，显示 201-210 项，共有 2808 项

1. 血液科- 临床试验- 妙佑医疗国际

   ... relapsed or resistant chronic lymphocytic leukemia. Patients will be ... Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL). Rochester ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   KTX-100 MMSET Catalytic Inhibitor that Suppresses H3K36me2 in Patients with Relapsed and Refractory Multiple Myeloma. Rochester, Minn., Jacksonville, Fla ...

3. 泌尿科- 临床试验- 妙佑医疗国际

   Patients at high risk of relapse are eligible for InPACT-pelvis, where they are randomised to either: P. prophylactic PLND Q. no prophylactic PLND. Rare ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   A Study of APG-2575 Alone or in Combination with Other Therapeutic Agents to Treat Relapsed and/or Refractory Chronic Lymphocytic Leukemia (CLL)/Small ...

5. 血液科- 临床试验- 妙佑医疗国际

   AZD0486 As Monotherapy In Participants With Relapsed/Refractory (R/R) B-cell NHL. Rochester, Minn. This is a Phase 2 global, multi-center, open-label study ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Inotuzumab Ozogamicin in Treating Younger Patients With Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia. Rochester, Minn. This phase II ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... Relapsed Or Refractory Chronic Lymphocytic Leukemia. Rochester, Minn. This study will assess the safety, tolerability, pharmaokinetics, and preliminary ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... Relapsed Or Refractory Chronic Lymphocytic Leukemia. Rochester, Minn. This study will assess the safety, tolerability, pharmaokinetics, and preliminary ...

9. 脑肿瘤项目- 临床试验- 妙佑医疗国际

   Also, to improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial response (PR) and ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL). Rochester ... Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL). A Blood ...